Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesDiscontinuation symptoms and taper/poststudy-emergent adverse events with desvenlafaxine treatment for major depressive disorder
International Clinical Psychopharmacology, 10/16/09
Montgomery SA et al. – Cessation of desvenlafaxine use is associated with discontinuation symptoms after both short–term and long–term treatment.
Related Articles
The relationship between major depression and marital disruption is bidirectional
Depression and Anxiety, 10/06/09
Relevance Score: 83%
Increased sensitivity to heat pain after sad mood induction in female patients with major depression
European Journal of Pain, 10/21/09
Relevance Score: 82%
Personality disorders improve in patients treated for major depression
Acta Psychiatrica Scandinavica, 11/13/09
Relevance Score: 81%
The role of ceramide in major depressive disorder
European Archives of Psychiatry and Clinical Neuroscience, 11/12/09
Relevance Score: 81%
Adjustment Disorder: Epidemiology, Diagnosis and Treatment
CNS Drugs, 10/29/09
Relevance Score: 81%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
Journal of Neuro-Oncology, 12/04/09
Combination therapy of 17(beta)-estradiol and recombinant tissue plasminogen activator for experimental ischemic stroke
Journal of Pharmacology and Experimental Therapeutics, 12/04/09
Glutamatergic (N-methyl-D-aspartate receptor) hypofrontality in schizophrenia: Too little juice or a miswired brain
Molecular Pharmacology, 12/04/09
Sponsor
Article Search
Sponsor